State Street’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.54B | Buy |
4,832,002
+42,343
| +0.9% | +$22.2M | 0.1% | 191 |
|
2025
Q1 | $3.04B | Sell |
4,789,659
-42,580
| -0.9% | -$27M | 0.13% | 153 |
|
2024
Q4 | $3.44B | Sell |
4,832,239
-70,165
| -1% | -$50M | 0.14% | 136 |
|
2024
Q3 | $5.15B | Buy |
4,902,404
+61,277
| +1% | +$64.4M | 0.21% | 85 |
|
2024
Q2 | $5.09B | Sell |
4,841,127
-421
| -0% | -$442K | 0.22% | 81 |
|
2024
Q1 | $4.66B | Sell |
4,841,548
-59,703
| -1% | -$57.5M | 0.21% | 93 |
|
2023
Q4 | $4.3B | Buy |
4,901,251
+72,145
| +1% | +$63.4M | 0.21% | 91 |
|
2023
Q3 | $3.97B | Sell |
4,829,106
-161,764
| -3% | -$133M | 0.22% | 89 |
|
2023
Q2 | $3.59B | Buy |
4,990,870
+97,254
| +2% | +$69.9M | 0.19% | 102 |
|
2023
Q1 | $4.02B | Sell |
4,893,616
-67,269
| -1% | -$55.3M | 0.23% | 91 |
|
2022
Q4 | $3.58B | Sell |
4,960,885
-90,874
| -2% | -$65.6M | 0.21% | 97 |
|
2022
Q3 | $3.48B | Sell |
5,051,759
-78,876
| -2% | -$54.3M | 0.22% | 89 |
|
2022
Q2 | $3.03B | Buy |
5,130,635
+5,168
| +0.1% | +$3.05M | 0.18% | 110 |
|
2022
Q1 | $3.58B | Buy |
5,125,467
+325,645
| +7% | +$227M | 0.18% | 111 |
|
2021
Q4 | $3.03B | Buy |
4,799,822
+159,817
| +3% | +$101M | 0.14% | 131 |
|
2021
Q3 | $2.81B | Buy |
4,640,005
+123,289
| +3% | +$74.6M | 0.15% | 128 |
|
2021
Q2 | $2.52B | Sell |
4,516,716
-30,585
| -0.7% | -$17.1M | 0.13% | 141 |
|
2021
Q1 | $2.15B | Sell |
4,547,301
-144,086
| -3% | -$68.2M | 0.12% | 159 |
|
2020
Q4 | $2.27B | Buy |
4,691,387
+33,849
| +0.7% | +$16.4M | 0.14% | 141 |
|
2020
Q3 | $2.61B | Buy |
4,657,538
+105,873
| +2% | +$59.3M | 0.18% | 109 |
|
2020
Q2 | $2.84B | Buy |
4,551,665
+934,332
| +26% | +$583M | 0.21% | 94 |
|
2020
Q1 | $1.77B | Buy |
3,617,333
+43,216
| +1% | +$21.1M | 0.15% | 132 |
|
2019
Q4 | $1.34B | Buy |
3,574,117
+44,258
| +1% | +$16.6M | 0.09% | 213 |
|
2019
Q3 | $979M | Buy |
3,529,859
+57,027
| +2% | +$15.8M | 0.07% | 275 |
|
2019
Q2 | $1.09B | Buy |
3,472,832
+7,781
| +0.2% | +$2.44M | 0.08% | 244 |
|
2019
Q1 | $1.42B | Buy |
3,465,051
+192,343
| +6% | +$79M | 0.11% | 190 |
|
2018
Q4 | $1.22B | Buy |
3,272,708
+39,487
| +1% | +$14.7M | 0.11% | 185 |
|
2018
Q3 | $1.31B | Sell |
3,233,221
-7,181
| -0.2% | -$2.9M | 0.1% | 197 |
|
2018
Q2 | $1.12B | Sell |
3,240,402
-59,113
| -2% | -$20.4M | 0.09% | 212 |
|
2018
Q1 | $1.14B | Sell |
3,299,515
-22,457
| -0.7% | -$7.73M | 0.1% | 212 |
|
2017
Q4 | $1.25B | Buy |
3,321,972
+77,548
| +2% | +$29.2M | 0.1% | 205 |
|
2017
Q3 | $1.45B | Sell |
3,244,424
-45,879
| -1% | -$20.5M | 0.13% | 170 |
|
2017
Q2 | $1.62B | Sell |
3,290,303
-89,848
| -3% | -$44.1M | 0.14% | 149 |
|
2017
Q1 | $1.31B | Buy |
3,380,151
+139,602
| +4% | +$54.1M | 0.12% | 185 |
|
2016
Q4 | $1.19B | Buy |
3,240,549
+68,675
| +2% | +$25.2M | 0.11% | 196 |
|
2016
Q3 | $1.28B | Buy |
3,171,874
+78,579
| +3% | +$31.6M | 0.13% | 169 |
|
2016
Q2 | $1.08B | Buy |
3,093,295
+15,272
| +0.5% | +$5.33M | 0.12% | 185 |
|
2016
Q1 | $1.11B | Buy |
3,078,023
+233
| +0% | +$84K | 0.12% | 178 |
|
2015
Q4 | $1.67B | Buy |
3,077,790
+47,975
| +2% | +$26M | 0.18% | 117 |
|
2015
Q3 | $1.41B | Buy |
3,029,815
+5,220
| +0.2% | +$2.43M | 0.16% | 127 |
|
2015
Q2 | $1.54B | Sell |
3,024,595
-95,229
| -3% | -$48.6M | 0.16% | 131 |
|
2015
Q1 | $1.41B | Sell |
3,119,824
-72,230
| -2% | -$32.6M | 0.14% | 149 |
|
2014
Q4 | $1.31B | Buy |
3,192,054
+53,497
| +2% | +$21.9M | 0.13% | 171 |
|
2014
Q3 | $1.13B | Sell |
3,138,557
-90,714
| -3% | -$32.7M | 0.12% | 183 |
|
2014
Q2 | $912M | Sell |
3,229,271
-24,884
| -0.8% | -$7.03M | 0.1% | 211 |
|
2014
Q1 | $977M | Sell |
3,254,155
-113,979
| -3% | -$34.2M | 0.11% | 195 |
|
2013
Q4 | $927M | Buy |
3,368,134
+98,441
| +3% | +$27.1M | 0.1% | 201 |
|
2013
Q3 | $1.02B | Buy |
3,269,693
+9,633
| +0.3% | +$3.01M | 0.13% | 171 |
|
2013
Q2 | $733M | Buy |
+3,260,060
| New | +$733M | 0.1% | 210 |
|